Bertram Pitt
Bertram Pitt is an expert in Cardiology at Michigan Medicine (United States). As of October 2026, ScienceLeadR ranks Bertram Pitt in the top 1% of experts worldwide for Hyperkalemia, Hypokalemia and Heart Failure. Bertram Pitt has authored 1,270 publications, the most recent in 2026, and is an investigator in 44 clinical trials. SLR score: 5,021 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Endocrinology - Nephrology - Pharmacy
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1976 - 2026
Number : 1270
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| SGLT1/2 inhibitor sotagliflozin, but not SGLT2-selective inhibitor empagliflozin, attenuates platelet activation and thrombosis. PMID 42873976 — diabetes mellitus, thrombosis, blood platelets, platelet activation, diabetes mellitus, type 2 | J Clin Invest | 2026 | 0 |
| Effectiveness of Finerenone in Slowing Chronic Kidney Disease Progression After Hospitalization for Heart Failure: A FIDELITY Subgroup Analysis. PMID 42803273 — kidney diseases, creatinine, hospitalization, serum, heart failure, heart, disease progression, kidney, therapeutics | Eur J Heart Fail | 2026 | 0 |
| Undiagnosed Chronic Kidney Disease, Outcomes, and Finerenone in Heart Failure: The FINEARTS-HF Randomized Clinical Trial. PMID 42776557 — kidney diseases, heart failure, heart, cardiovascular diseases, kidney | JAMA Cardiol | 2026 | 0 |
| Phenotype-specific prognostic implications of pulse pressure in heart failure. PMID 42725585 — hospitalization, heart failure, heart, phenotype, heart failure, diastolic, heart failure, systolic, prognosis, pulse | Eur J Heart Fail | 2026 | 0 |
| Short-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassium. PMID 42675244 — blood, serum, heart failure, molecular biology, heart, blood pressure, heart failure, diastolic, kidney, heart failure, systolic, therapeutics | Nat Med Top journal | 2026 | 0 |
Clinical Studies 44
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map